VC-backed Harpoon Therapeutics appoints CFO
MPM Capital-backed Harpoon Therapeutics Inc, which is developing multiple T-cell recruiting platforms to treat cancer patients, has named William E. Picht Jr. as chief financial officer. Previously, Picht was CFO at Pearl Therapeutics.
26 January 2017•3 mins read
